§ 21-129 Opioid antagonist administration training.
AC § 21-129
a. Definitions. For the purposes of this section, the following terms have the following meanings: HASA facility. The term "HASA facility" means single room occupancy hotels or congregate facilities managed by a provider under contract or similar agreement with the department. Opioid. The term "opioid" means an opiate as defined in section 3302 of the public health law. Opioid antagonist. The term "opioid antagonist" means naloxone or other medication approved by the New York state department of health and the federal food and drug administration that, when administered, negates or neutralizes, in whole or in part, the pharmacological effects of an opioid in the human body. Opioid antagonist administration training. The term "opioid antagonist administration training" means a program with the purpose of training individuals encountering a suspected opioid overdose about the steps to take in order to prevent a fatality, including contacting emergency medical services, and administering an opioid antagonist. b. Opioid antagonist administration training.
1.The department shall provide opioid antagonist administration training to staff working at HASA facilities as identified by the department that may encounter persons experiencing or who are at high risk of experiencing an opioid overdose. The department shall require providers to ensure that at a minimum one such trained staff is on duty at a HASA facility at all times during the provider's usual business hours.
2.For such staff identified by the department, the department shall (i) provide a refresher training every two years or (ii) otherwise require that each trained employee undergo a refresher training every two years.
3.The department shall develop and implement an opioid overdose training plan to offer opioid overdose training to residents of HASA facilities who may encounter persons experiencing or who are at a high risk of experiencing an opioid overdose. No later than March 1, 2018, the commissioner of the department of social services shall submit to the mayor and the speaker of the council, and post online, a comprehensive opioid overdose training plan for such residents. Such plan shall include, but need not be limited to: (a) Strategies for the agency to offer opioid antagonist administration training to such residents of HASA facilities; (b) Information on how such residents will be informed about the availability of such training; (c) Information specific to the availability of such training; (d) Information specific to the availability of opioid antagonist at HASA facilities; and (e) The date by which the implementation of such plan will commence. c. Beginning no later than September 1, 2018, and no later than every September 1 thereafter, the commissioner shall submit to the mayor and the speaker of the council an annual report regarding (i) the number of department employees and employees of service providers under contract with the department who have completed the opioid antagonist administration training, (ii) the number of department employees and employees of service providers under contract with the department who have completed a refresher training, and (iii) the number of residents living HASA facilities who have completed the opioid antagonist administration training. Such report shall also include the number of times an opioid antagonist was administered to a resident disaggregated by the type of facility where the administration occurred. (L.L. 2017/225, 12/1/2017, eff. 12/1/2017)
